Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study

Figure 2

Cumulative incidence among a propensity score-matched cohort of patients on metformin and nonmetformin monotherapy: (a) all-cause death; (b) cardiovascular death; (c) heart failure; (d) heart failure hospitalization. CI = cumulative incidence.

(a)

(b)

(c)

(d)